Abstract:Actinomycetes have long been recognized as an important source of antibacterial natural products. In recent years, actinomycetes in extreme environments have become one of the main research directions. Streptomyces sp. KN37 was isolated from the cold region of Kanas in Xinjiang. It demonstrated potent antimicrobial activity, but the primary active compounds remained unclear. Therefore, we aimed to combine genomics with traditional isolation methods to obtain bioactive compounds from the strain KN37. Whole-genome sequencing and KEGG enrichment analysis indicated that KN37 possesses the potential for synthesizing secondary metabolites, and 41 biosynthetic gene clusters were predicted, some of which showed high similarity to known gene clusters responsible for the biosynthesis of antimicrobial antibiotics. The traditional isolation methods and activity-guided fractionation were employed to isolate and purify seven compounds with strong bioactivity from the fermentation broth of the strain KN37. These compounds were identified as 4-(Diethylamino)salicylaldehyde (1), 4-Nitrosodiphenylamine (2), N-(2,4-Dimethylphenyl)formamide (3), 4-Nitrocatechol (4), Methylsuccinic acid (5), Phenyllactic acid (6) and 5,6-Dimethylbenzimidazole (7). Moreover, 4-(Diethylamino)salicylaldehyde exhibited the most potent inhibitory effect against Rhizoctonia solani, with an EC50 value of 14.487 mg/L, while 4-Nitrosodiphenylamine showed great antibacterial activity against Erwinia amylovora, with an EC50 value of 5.715 mg/L. This study successfully isolated several highly active antimicrobial compounds from the metabolites of the strain KN37, which could contribute as scaffolds for subsequent chemical synthesis. On the other hand, the newly predicted antibiotic-like substances have not yet been isolated, but they still hold significant research value. They are instructive in the study of active natural product biosynthetic pathways, activation of silent gene clusters, and engineering bacteria construction.

New bioactive secondary metabolites from the soil-derived Streptomyces sp. S045 and their anti-bacterial and anti-type III secretion system activities

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

New analogues of amides and quinolinones produced by Streptomyces sp. YIM S01983

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Suncheonosides E-M and Benzothioate Derivatives from the Marine-Derived Streptomyces sp. ZSN77

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Streptoindoles A–D, Novel Antimicrobial Indole Alkaloids from the Marine-Associated Actinomycete Streptomyces Sp. ZZ1118

Bioactive Staurosporine Derivatives from the Streptomyces Sp. NB-A13.

A new xanthostatin analogue from the marine sponge-associated actinomycete Streptomyces sp. SCSIO 40064

Nitricquinomycins A-C, Uncommon Naphthopyrrolediones from the Streptomyces Sp. ZS-A45

Antibiofilm Metabolites from Marine-derived Streptomyces sp. ZS-A31

Novel antibacterial alkaloids from the Mariana Trench-derived actinomycete Streptomyces sp. SY2255

Integrative Genomics and Bioactivity-Guided Isolation of Novel Antimicrobial Compounds from Streptomyces sp. KN37 in Agricultural Applications

New antimicrobial compounds produced by Seltsamia galinsogisoli sp. nov., isolated from Galinsoga parviflora as potential inhibitors of FtsZ

A new benzodioxole derivative from the marine-derived Streptomyces sp. SYPHU 0002

New secondary metabolites from an engineering mutant of endophytic Streptomyces sp. CS

Isolation, identification and antimicrobial activities of two secondary metabolites of Talaromyces verruculosus

Mollicellins S-U, Three New Depsidones from Chaetomium Brasiliense SD-596 with Anti-Mrsa Activities